Company intelligence / Profile preview

Clinigen

Burton-on-Trent, Staffordshire, UKclinigengroup.com ↗

Ownership: Public · CLIN
Employees: ~1000
Development stage: Commercial

Overview

Clinigen specializes in providing ethical access to medicines globally, including commercialized drugs and those not yet approved in all territories. The company partners with pharma firms to manage the lifecycle of products from clinical trials through post-marketing supply. It does not focus on novel drug discovery but enables patient access to essential therapies worldwide.

Therapeutic areas: GastroenterologyOphthalmologyRare DiseasesNeurology
Modalities: Small molecule
Industry: Contract Research Organization

Partnerships

Essential PharmaTepsivoFishawack Health

Financials

Market cap: $83.5M
Total revenue: $0
Enterprise value: $89.6M

Beyond the preview

Go deeper on Clinigen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinigen.

Explore the full profile